Publication:
Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome

dc.contributor.authorEren, Erdal
dc.contributor.buuauthorAbuhandan, Mahmut
dc.contributor.buuauthorSolmaz, Abdullah
dc.contributor.buuauthorTaşkın, Abdullah
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentBiyokimya Ana Bilim Dalı
dc.contributor.departmentPediatri Ana Bilim Dalı
dc.contributor.researcheridABF-5740-2020
dc.contributor.scopusid6603208583
dc.contributor.scopusid55941048500
dc.contributor.scopusid35204100300
dc.date.accessioned2024-03-01T05:46:53Z
dc.date.available2024-03-01T05:46:53Z
dc.date.issued2014-07-07
dc.description.abstractObjective: This study aimed to measure paraoxonase/arylesterase activities and to evaluate the total oxidant and antioxidant capacities in obese children and in children with metabolic syndrome (MetS). Methods: A total of 151 children of comparable ages (13.23+/-1.96 years, 13.45+/-1.85 years and 13.95+/-1.31 years) were enrolled in the study. Forty of these were children with MetS, 55 were obese and 56 were healthy controls. Diagnosis of the MetS was made according to International Diabetes Federation criteria. Paraoxonase/arylesterase activities were evaluated by using paraoxon and phenylacetate substrates. Total oxidant status (TOS) and total antioxidant status (TAS) were measured and oxidative stress index (OSI) was estimated by calculation. Results: High levels of paraoxonase were detected in the obese group, whereas high levels of arylesterase were detected in both MetS and obese groups. Higher values for TOS, TAS and OSI were found in the MetS group (p<0.05). Conclusion: Higher values of mean TOS and OSI in the MetS group than those in the control groups indicate that these parameters may be indicators of future risks such as atherosclerosis in patients with MetS.
dc.identifier.citationEren, E. vd. (2014). "Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome". JCRPE Journal of Clinical Research in Pediatric Endocrinology, 6(3), 163-168.
dc.identifier.doihttps://doi.org/10.4274/jcrpe.1454
dc.identifier.eissn1308-5735
dc.identifier.endpage168
dc.identifier.issn1308-5727
dc.identifier.issue3
dc.identifier.pubmed25241610
dc.identifier.scopus2-s2.0-84908218387
dc.identifier.startpage163
dc.identifier.urihttps://cms.galenos.com.tr/Uploads/Article_1191/163-168.pdf
dc.identifier.urihttps://hdl.handle.net/11452/40116
dc.identifier.volume6
dc.identifier.wos000347784500005
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherGalenos Yayıncılık
dc.relation.collaborationYurt içi
dc.relation.journalJCRPE Journal of Clinical Research in Pediatric Endocrinology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMetabolic syndrome
dc.subjectPediatrics
dc.subjectObesity
dc.subjectEndocrinology & metabolism
dc.subjectOxidative stress
dc.subjectPon1 activity
dc.subjectParaoxonase
dc.subjectRisk-factors
dc.subjectFatty liver-disease
dc.subjectAdipokine levels
dc.subjectC-reactive protein
dc.subjectAutomated-method
dc.subjectInsulin-resistance
dc.subjectChildhood obesity
dc.subjectObese children
dc.subjectParaoxonase activity
dc.subject.emtreeAdolescent
dc.subject.emtreeArticle
dc.subject.emtreeBody height
dc.subject.emtreeBody mass
dc.subject.emtreeChild
dc.subject.emtreeControlled study
dc.subject.emtreeEnzyme activity
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeInsulin resistance
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMetabolic syndrome x
dc.subject.emtreeObesity
dc.subject.emtreeOxidative stress
dc.subject.emtreeSchool child
dc.subject.emtreeWaist circumference
dc.subject.emtreeBlood
dc.subject.emtreeCase control study
dc.subject.emtreeEnzymology
dc.subject.emtreeMetabolic syndrome x
dc.subject.emtreePediatric obesity
dc.subject.emtreePredictive value
dc.subject.emtreeRisk factor
dc.subject.emtreeUpregulation
dc.subject.emtreeAryldialkylphosphatase
dc.subject.emtreeArylesterase
dc.subject.emtreeOxidizing agent
dc.subject.emtreeAntioxidant
dc.subject.emtreeAryldialkylphosphatase
dc.subject.emtreeBiological marker
dc.subject.emtreeC reactive protein
dc.subject.emtreePon1 protein, human
dc.subject.meshAdolescent
dc.subject.meshAntioxidants
dc.subject.meshAryldialkylphosphatase
dc.subject.meshBiomarkers
dc.subject.meshC-reactive protein
dc.subject.meshCase-control studies
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMetabolic syndrome x
dc.subject.meshOxidative stress
dc.subject.meshPediatric obesity
dc.subject.meshPredictive value of tests
dc.subject.meshRisk factors
dc.subject.meshUp-regulation
dc.subject.scopusAryldialkylphosphatase; Arylesterase; Oxidative Stress
dc.subject.wosEndocrinology & metabolism
dc.subject.wosPediatrics
dc.titleSerum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome
dc.typeArticle
dc.wos.quartileQ4 (Endocrinology & metabolism)
dc.wos.quartileQ2 (Pediatrics)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Pediatri Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Biyokimya Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Abuhandan_vd_2014
Size:
112.58 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: